View more on these topics

RSAE and Framlington team up

Royal & SunAlliance Eurolife

RSAE Framlington Health Fund

Type: Sicav

Aim: Growth by investing in healthcare, medical services and product


Minimum investment: Lump sum Euro 15,000

Place of registration: Luxemburg

Investment split: 100% in healthcare, medical services and product


Isa link: No

Charges: Initial 0.5%, annual 1.5%

Commission: Initial 5%

Tel: 00353 15009100

Broker Panel:-

Brian Pack – Principal, Brian Pack Financial Services

John Hill – IFA, Positive Solutions

Jeremy Marsh – Investment manager, Lupton Fawcett

Broker Ratings:-

Suitability to market: 5.7

Investment strategy: 7.3

Company’s reputation: 6.0

Charges: 4.3

Commission: 6.0

Product literature: 4.3

Royal & SunAlliance Eurolife has introduced the RSAE

Framlington health fund, a Sicav investing in healthcare, medical

services and product companies.

When asked how the product fits into the market, Pack says:

"It is entering a crowded market with the big boys of pan

Europe." Hill thinks it is a speculative product, saying that

biotech has been having some spectacular failure recently.

Marsh says: "It fits well as one of the few providers with a

pedigree in this sector."

Looking at the type of client the Sicav may be suitable for, Hill says:

"Younger clients who expect this type of company to lead

the world."

Pack thinks that people who are prepared to accept some risk to

obtain good growth will like the product. Marsh says: "Most

clients with a moderate plus risk acceptance could have this in a

portfolio of £100,000 plus."

Moving on to the marketing opportunities offered by the product, Pack

says he can see none to his clients. Marsh says: "For the

clients, it is a good opportunity because of the current low prices for

those wanting such a fund." Hill says: "The

opening will be there at a time when the biotechs are a


Considering the main useful features and strong points of the

product, Marsh says: "It invests in a good and growing

sector, and currently has a low price."

Hill thinks healthcare will always be in the market, and the need for

this comes from the ageing population. Pack says:

"Framlington has built a very strong team who specialise

in healthcare."

When asked to identify the disadvantages of the Sicav, Hill says:

"The failures of the sector get big press

coverage." Pack picks out the bid/offer spread which he

thinks is high, and Royal & SunAlliance’s

declining reputation. He adds that the fund is subject to currency


Marsh says: "None except must be part of a larger portfolio

due to its longer term nature. This is because its success is reliant

on legislative changes."

The panel is not impressed by the flexibility offered by the fund. Marsh

says there is not much flexibility. Pack says: "The bid/offer

spread is high, which cuts out the flexibility in moving funds

around." Hill says the flexibility is okay, but that there is

better around.

Considering the investment strategy of the fund, Marsh says:

"It is not that different from other healthcare companies.

Healthcare is a growing market area. It is fine for the long term, but

for the short term it is probably the most volatile fund in its


Hill does not have a problem with the investment strategy. Pack

thinks the strategy is quite good, and the sort of thing that you would

expect from a healthcare fund.

Turning to the reputation of Royal & SunAlliance Eurolife,

Hill says he is not particularly impressed. He says: "It is

not an all singing, all dancing attraction. It does not back up what it

says. The sales pitch is not supported by the



BoE says equity dip will hit savings

The Bank of England monetary policy committee claims that savings levels in the UK are threatened by consumers&#39 existing exposure to the stockmarket through with-profits and mutual funds because of market volatility. The minutes of the last MPC meeting held on July 31 and August 1 say that higher levels of private pensions and equity-linked […]

Raising standards consults on mergers

If a merger were to take place between two life offices both having the Raising Standards Quality mark, they could retain their kitemark according to proposals published by the scheme this week.But if a life office were to take over or be bought by a rival without the quality mark, the other life office would […]

Global Investment Advisers – GAIM Market Neutral Hedge Fund

Thursday, 22 August 2002 Type: Tracker fund of hedge funds Aim: Growth by investing in up to 20 hedge funds in the equity market neutral and convertible arbitrage indices Minimum investment: Lump sum $100,000, euros 100,000 Place of registration: Dublin Investment split: 100% in up to 20 hedge funds in the equity market neutral and […]

Julian Gibbs

Last month saw the launch of Nvesta, a specialist financial product provider that designs, implements and manages investment plans for UK investors. It is part of Eurolife Group, a market leader in this sector for many years. Its first offering is the Capital Secure FTSE plan, which guarantees a 100 per cent capital return plus […]

Indian market rallies as Modi's popularity strengthens

Kunal Desai, manager of the Neptune India Fund, comments on the implications of the BJP’s historic election win in India’s most populous state, Uttar Pradesh. Read the full article here Important Information – for investment professionals only. Not for retail clients.  Investment risks  The Neptune India Fund may have a high volatility rating and past […]


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm